[Multiple sclerosis: immunomodulators, education, and self-injection].

Rev Neurol (Paris) 2007 Dec;163(12):1209-13

Service de Neurologie, CHU La Mil├ętrie, Poitiers.

One hundred and sixty four patients of the Poitou-Charentes area suffering from multiple sclerosis (MS) and treated with an immunomodulating agent for more than 3 months completed a self-administered questionnaire. More than 60p.cent of the patients performed self-injection. For both modes of injection studied (subcutaneous or intramuscular), self-injection was significantly more frequent among patients who were received training and followed via telephone assistance conducted by a nurse with specialized training in MS. Our study demonstrated that waste disposal (needles), especially among patients performing self-injections, remains an important problem. Efforts must be taken concerning this important healthcare issue.

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S003537870778405
Publisher Site
http://dx.doi.org/10.1016/S0035-3787(07)78405-9DOI Listing
December 2007

Publication Analysis

Top Keywords

questionnaire 60pcent
4
needles patients
4
60pcent patients
4
disposal needles
4
patients performed
4
self-administered questionnaire
4
training study
4
training telephone
4
agent months
4
months completed
4
patients performing
4
completed self-administered
4
performed self-injection
4
received training
4
intramuscular self-injection
4
subcutaneous intramuscular
4
study demonstrated
4
self-injection frequent
4
frequent patients
4
patients received
4

Similar Publications